WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor

VA & Hepatitis C: Over 80,000 patients – 90% cure rate. Get tested now!
May 12, 2017
Medical History Reveals Multiple Sclerosis Begins to Impact Patients Sooner
May 12, 2017
Show all

WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor

There is a new pilot project about biosimilar cancer medications.

The World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make such medicines more widely available in poorer countries.

The U.N. agency said on Thursday it would invite drugmakers in September to submit applications for prequalification of so-called biosimilar versions of two such drugs on its essential medicines list, Roche’s Rituxan and Herceptin.

WHO also plans to explore options for prequalifying biosimilar insulin.

The move is a boost for biosimilars which are expected to account for a growing proportion of treatments, particularly for cancer, as patents on the original branded products expire.

Read full article: WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor – Scientific American

Read Full Article: WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor – Scientific American

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.